Eosinophilic esophagitis (EoE) is a chronic (long-term) condition affecting the esophagus, the tube that carries food and liquids from the mouth to the stomach. EoE causes symptoms like difficulty ...

Eosinophilic esophagitis (EoE) occurs when white blood cells called eosinophils build up in the esophagus, the tube that ...

In tonight’s Avera Medical Minute, we introduce you to a Sioux Falls woman who thanks her mother’s intuition for helping ...

Eosinophilic esophagitis (EoE) is an allergic condition that causes inflammation in a person’s esophagus, which is the food pipe. People with EoE may need to avoid certain foods that trigger symptoms.

Etrasimod, a once-daily oral selective sphingosine-1-phosphate receptor modulator, is well tolerated and effective in treating eosinophilic esophagitis (EoE), demonstrating sustained histologic and ...

On Tuesday, Celldex Therapeutics, Inc. (NASDAQ:CLDX) released topline results from its ongoing Phase 2 study of barzolvolimab in eosinophilic esophagitis (EoE), a chronic inflammatory disease of the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Eosinophilic esophagitis (EoE) is a prevalent condition ...

Dupilumab is a human monoclonal antibody that blocks interleukin-4 and interleukin-13 pathways and has shown efficacy in five different atopic diseases marked by type 2 inflammation, including ...

Looking for an eosinophilic esophagitis (EoE) doctor? Whether you've just been diagnosed or you've been managing the condition for a while, it's likely you'll need more than one healthcare ...

First patient dosed, with topline results expected in 2027pHalcon-EoE-201 is the first large, well-controlled clinical trial of an acid secretory treatment in EoE FLORHAM PARK, N.J., Nov. 04, 2025 ...

Clinical Remission: Rapid and meaningful induction of clinical remission observed as measured by the Straumann Dysphagia Index (SDI). Tissue Health and Eosinophil Reduction: Greatest improvements to ...

Benralizumab is an eosinophil-depleting anti–interleukin-5 receptor α monoclonal antibody. The efficacy and safety of benralizumab in patients with eosinophilic esophagitis are unclear. In a phase 3, ...